Industry and Tata Asset Management AUM has grown by a healthy 29% till YTD 2024. Our Equity and Balanced AUM growth has been in line with the industry. Our AUM has grown higher in Debt and Ultra compared to the industry.
Q. The year saw large caps return in focus. Do you think that they will continue to be favoured as valuations in the mid- and small-cap segments remain overstretched, especially post Q2FY25 earnings season?
Mid and small caps are trading at premium to large caps. Some of that is justified by the nature of the economic growth that has been led by the investment cycle recovery which benefits the sectors that are small cap and midcap dominated. However, the risk reward seems better in large caps at this stage. In a significant part of the large cap sectors, the valuations have become reasonable, and growth could surprise on the upside in FY26. On the other hand, the expectations on mid and small caps in terms of earnings growth are on the higher side and could see disappointment if there are execution challenges or persistent macro slowdown.
Q. Thematic funds had a dream run in 2023 but failed to meet expectations in 2024. Do you think they’re on track to make a strong comeback in 2025?
The trend for thematic returns in the market in the last 12-24 months has come to an end in our view. While sectors like manufacturing, defence, Capital goods and Power still offer potential over the long run, it is likely to be a more stock-specific market from now on, even in these sectors with tailwinds. This is because of the raised expectations and valuations.
Q. What kind of investors do you think can take exposure to this category of funds?
この記事は Investors India の January 2025 版に掲載されています。
7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、9,000 以上の雑誌や新聞にアクセスしてください。
すでに購読者です ? サインイン
この記事は Investors India の January 2025 版に掲載されています。
7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、9,000 以上の雑誌や新聞にアクセスしてください。
すでに購読者です? サインイン
A Doctor Within You: Your Immune System
The fact that you survive is due to your immune system-a fascinating network of chemicals and cells that protect your body.
PERSON OF THE YEAR 2024
Like every year there were many contenders. Don is back dodging bullets by the ear. He can claim the year. Criminal convictions?
Indian Mutual Fund Industry in 2025 What Lies Ahead?
Q. How do you view the performance of the MF industry, in general, and your fund house, in particular, during 2024?
Add Health to Your Wealth
Life is unpredictable because it is influenced by countless unpredictable factors such as accidents, illness, economic changes, natural disasters or personal circumstances.
Market strategy for the year 2025
India’s GDP print came in lower than expectations at 5.4% substantially lower than 6.7% recorded in Q1 FY’25 and 8.1% in Q2 FY’24 seems mainly by a slowdown in government expenditure and capital formation.
Review and Rebalance Your Portfolio at the Start of 2025
At the start of 2025, investors must review their investment portfolios and bring about certain changes to prepare them for the challenges of the new year. Let us begin by reviewing the year that has gone by, and then discuss the changes you need to make to your portfolio.
An Overview on Asset Allocation
The recent sharp volatility in the stock markets has retail investors worried, especially those who put all their funds into equity and completely ignored fixed income/debt and gold.
Indians are Developing Weak Bones
In India, 1 out of 8 males and 1 out of 3 females suffer from osteoporosis, making India one of the largest affected countries in the world.
"The strategy behind the Tata India Innovation Fund centers on identifying companies that are driving transformative or incremental changes through innovation"
Yes, we certainly believe innovation is a powerful theme with immense potential for the coming years, and we are excited to bring it to our investors.
What is Hybrid Mutual Fund?
Hybrid Mutual Fund is a combination of more than one type of fund. While they invest in shares of companies listed on the exchange, like equity funds.